COVID-19. Thromboinflammation and thrombosis

The authors of the book have for the first time summarized the accumulated information on the mechanisms of vascular and intravascular complications in COVID-19, including the role of neutrophil extracellular traps, thrombotic microangiopathy, coagulopathy, shed light on aspects of laboratory monitoring of coagulopathy markers in patients with COVID-19, identified risk groups for thromboembolic complications and vaccine-induced thrombocytopenia. The guide provides a deep understanding of the use of anticoagulant therapy in patients with COVID-19. It discusses the multifaceted effects of heparins, their anticoagulant and non-anticoagulant properties. The publication offers a comprehensive understanding of the complex relationship between COVID-19, inflammation, and hemostasis disorders, shedding light on various pathophysiological mechanisms and providing valuable information for diagnosis, risk assessment, and potential therapeutic interventions. The book is a comprehensive study of the relationship between COVID-19, inflammation, and hemostasis disorders. This work is a valuable resource for deepening our understanding of COVID-19-associated vascular complications and optimizing patient treatment outcomes. This book is aimed at a wide range of medical professionals - specialists in various therapeutic fields.